A high stakes game

A high stakes game

Today at around 11am central time March Madness will officially begin and worker productivity will plummet. When it’s all over shortly after April Fool’s Day a champion will be crowned and some lucky alumni will have bragging rights until the madness starts all over next year. Medtronic (NYSE: MDT) is about to begin their own madness with the rollout of the 670G. While this rollout will be limited to a handful of patients, this is perhaps one of the most important product launches in diabetes device history and not just for Medtronic . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.